annual retained earnings:
$31.67B+$4.41B(+16.19%)Summary
- As of today (May 31, 2025), REGN annual retained earnings is $31.67 billion, with the most recent change of +$4.41 billion (+16.19%) on December 31, 2024.
- During the last 3 years, REGN annual retained earnings has risen by +$12.70 billion (+66.98%).
- REGN annual retained earnings is now at all-time high.
Performance
REGN Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
$32.38B+$711.50M(+2.25%)Summary
- As of today (May 31, 2025), REGN quarterly retained earnings is $32.38 billion, with the most recent change of +$711.50 million (+2.25%) on March 31, 2025.
- Over the past year, REGN quarterly retained earnings has increased by +$4.40 billion (+15.73%).
- REGN quarterly retained earnings is now at all-time high.
Performance
REGN quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
REGN Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.2% | +15.7% |
| 3 y3 years | +67.0% | +62.4% |
| 5 y5 years | +329.2% | +304.6% |
REGN Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.0% | at high | +62.4% |
| 5 y | 5-year | at high | +329.2% | at high | +304.6% |
| alltime | all time | at high | +2599.2% | at high | +2655.3% |
REGN Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $32.38B(+2.2%) |
| Dec 2024 | $31.67B(+16.2%) | $31.67B(+3.0%) |
| Sep 2024 | - | $30.76B(+4.6%) |
| Jun 2024 | - | $29.41B(+5.1%) |
| Mar 2024 | - | $27.98B(+2.6%) |
| Dec 2023 | $27.26B(+17.0%) | $27.26B(+4.4%) |
| Sep 2023 | - | $26.10B(+4.0%) |
| Jun 2023 | - | $25.09B(+4.0%) |
| Mar 2023 | - | $24.12B(+3.5%) |
| Dec 2022 | $23.31B(+22.9%) | $23.31B(+5.4%) |
| Sep 2022 | - | $22.11B(+6.3%) |
| Jun 2022 | - | $20.79B(+4.3%) |
| Mar 2022 | - | $19.94B(+5.1%) |
| Dec 2021 | $18.97B(+74.1%) | $18.97B(+13.3%) |
| Sep 2021 | - | $16.74B(+10.8%) |
| Jun 2021 | - | $15.11B(+25.8%) |
| Mar 2021 | - | $12.01B(+10.2%) |
| Dec 2020 | $10.89B(+47.6%) | $10.89B(+11.8%) |
| Sep 2020 | - | $9.74B(+9.5%) |
| Jun 2020 | - | $8.90B(+11.2%) |
| Mar 2020 | - | $8.00B(+8.5%) |
| Dec 2019 | $7.38B(+40.5%) | $7.38B(+12.0%) |
| Sep 2019 | - | $6.59B(+11.3%) |
| Jun 2019 | - | $5.92B(+3.4%) |
| Mar 2019 | - | $5.73B(+9.0%) |
| Dec 2018 | $5.25B(+78.3%) | $5.25B(+18.5%) |
| Sep 2018 | - | $4.43B(+15.5%) |
| Jun 2018 | - | $3.84B(+16.8%) |
| Mar 2018 | - | $3.29B(+11.6%) |
| Dec 2017 | $2.95B(+68.6%) | $2.95B(+6.3%) |
| Sep 2017 | - | $2.77B(+16.3%) |
| Jun 2017 | - | $2.38B(+19.4%) |
| Mar 2017 | - | $2.00B(+14.2%) |
| Dec 2016 | $1.75B(+105.0%) | $1.75B(+16.9%) |
| Sep 2016 | - | $1.50B(+21.5%) |
| Jun 2016 | - | $1.23B(+20.8%) |
| Mar 2016 | - | $1.02B(+19.4%) |
| Dec 2015 | $852.70M(+293.6%) | $852.70M(+22.2%) |
| Sep 2015 | - | $697.71M(+43.2%) |
| Jun 2015 | - | $487.31M(+66.5%) |
| Mar 2015 | - | $292.67M(+35.1%) |
| Dec 2014 | $216.64M(-333.7%) | $216.64M(+49.2%) |
| Sep 2014 | - | $145.21M(+121.7%) |
| Jun 2014 | - | $65.49M(-340.3%) |
| Mar 2014 | - | -$27.25M(-70.6%) |
| Dec 2013 | -$92.69M(-82.1%) | -$92.69M(-51.1%) |
| Sep 2013 | - | -$189.50M(-42.7%) |
| Jun 2013 | - | -$330.80M(-20.9%) |
| Mar 2013 | - | -$418.18M(-19.1%) |
| Dec 2012 | -$517.05M(-59.2%) | -$517.05M(-47.6%) |
| Sep 2012 | - | -$987.46M(-16.2%) |
| Jun 2012 | - | -$1.18B(-6.1%) |
| Mar 2012 | - | -$1.26B(-0.9%) |
| Dec 2011 | -$1.27B(+21.2%) | -$1.27B(+4.4%) |
| Sep 2011 | - | -$1.21B(+5.4%) |
| Jun 2011 | - | -$1.15B(+5.7%) |
| Mar 2011 | - | -$1.09B(+4.2%) |
| Dec 2010 | -$1.05B(+11.1%) | -$1.05B(+1.4%) |
| Sep 2010 | - | -$1.03B(+3.4%) |
| Jun 2010 | - | -$997.09M(+2.6%) |
| Mar 2010 | - | -$971.62M(+3.2%) |
| Dec 2009 | -$941.10M(+7.8%) | -$941.10M(+4.0%) |
| Sep 2009 | - | -$904.61M(+0.1%) |
| Jun 2009 | - | -$903.59M(+1.1%) |
| Mar 2009 | - | -$893.41M(+2.3%) |
| Dec 2008 | -$873.26M | -$873.26M(+3.4%) |
| Sep 2008 | - | -$844.41M(+2.6%) |
| Jun 2008 | - | -$823.29M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | -$804.84M(+1.5%) |
| Dec 2007 | -$793.22M(+15.4%) | -$793.22M(+1.7%) |
| Sep 2007 | - | -$780.15M(+4.8%) |
| Jun 2007 | - | -$744.31M(+3.7%) |
| Mar 2007 | - | -$717.53M(+4.4%) |
| Dec 2006 | -$687.62M(+17.5%) | -$687.62M(+4.7%) |
| Sep 2006 | - | -$656.65M(+4.4%) |
| Jun 2006 | - | -$629.24M(+3.9%) |
| Mar 2006 | - | -$605.66M(+3.5%) |
| Dec 2005 | -$585.28M(+19.5%) | -$585.28M(+5.3%) |
| Sep 2005 | - | -$555.61M(+6.7%) |
| Jun 2005 | - | -$520.96M(+5.5%) |
| Mar 2005 | - | -$493.96M(+0.8%) |
| Dec 2004 | -$489.83M(-7.8%) | -$489.83M(-0.6%) |
| Sep 2004 | - | -$492.63M(+2.3%) |
| Jun 2004 | - | -$481.55M(+3.1%) |
| Mar 2004 | - | -$467.00M(-12.1%) |
| Dec 2003 | -$531.53M(+25.3%) | -$531.53M(+3.8%) |
| Sep 2003 | - | -$512.16M(+6.1%) |
| Jun 2003 | - | -$482.92M(+6.3%) |
| Mar 2003 | - | -$454.19M(+7.1%) |
| Dec 2002 | -$424.07M(+41.5%) | -$424.07M(+9.2%) |
| Sep 2002 | - | -$388.38M(+9.2%) |
| Jun 2002 | - | -$355.57M(+9.4%) |
| Mar 2002 | - | -$325.14M(+8.5%) |
| Dec 2001 | -$299.70M(+34.1%) | -$299.70M(+10.5%) |
| Sep 2001 | - | -$271.32M(+7.9%) |
| Jun 2001 | - | -$251.39M(+6.3%) |
| Mar 2001 | - | -$236.56M(+5.8%) |
| Dec 2000 | -$223.52M(+11.6%) | -$223.52M(+4.6%) |
| Sep 2000 | - | -$213.78M(+1.5%) |
| Jun 2000 | - | -$210.57M(+1.4%) |
| Mar 2000 | - | -$207.62M(+3.7%) |
| Dec 1999 | -$200.30M(+13.0%) | -$200.30M(+0.7%) |
| Sep 1999 | - | -$198.90M(+2.5%) |
| Jun 1999 | - | -$194.00M(+4.2%) |
| Mar 1999 | - | -$186.20M(+5.1%) |
| Dec 1998 | -$177.20M(+5.1%) | -$177.20M(+3.2%) |
| Sep 1998 | - | -$171.70M(+0.8%) |
| Jun 1998 | - | -$170.30M(-1.2%) |
| Mar 1998 | - | -$172.40M(+2.3%) |
| Dec 1997 | -$168.60M(+7.4%) | -$168.60M(-0.3%) |
| Sep 1997 | - | -$169.10M(+1.1%) |
| Jun 1997 | - | -$167.20M(+2.6%) |
| Mar 1997 | - | -$163.00M(+3.8%) |
| Dec 1996 | -$157.00M(+26.0%) | -$157.00M(+5.4%) |
| Sep 1996 | - | -$148.90M(+6.4%) |
| Jun 1996 | - | -$140.00M(+5.7%) |
| Mar 1996 | - | -$132.40M(+6.3%) |
| Dec 1995 | -$124.60M(+23.2%) | -$124.60M(+6.7%) |
| Sep 1995 | - | -$116.80M(+6.6%) |
| Jun 1995 | - | -$109.60M(+4.1%) |
| Mar 1995 | - | -$105.30M(+4.2%) |
| Dec 1994 | -$101.10M(+43.6%) | -$101.10M(+6.0%) |
| Sep 1994 | - | -$95.40M(+4.4%) |
| Jun 1994 | - | -$91.40M(+12.6%) |
| Mar 1994 | - | -$81.20M(+15.3%) |
| Dec 1993 | -$70.40M(+130.1%) | -$70.40M(+19.5%) |
| Sep 1993 | - | -$58.90M(+19.5%) |
| Jun 1993 | - | -$49.30M(+23.6%) |
| Mar 1993 | - | -$39.90M(+30.4%) |
| Dec 1992 | -$30.60M(+168.4%) | -$30.60M(+26.4%) |
| Sep 1992 | - | -$24.20M(+31.5%) |
| Jun 1992 | - | -$18.40M(+25.2%) |
| Mar 1992 | - | -$14.70M(+28.9%) |
| Dec 1991 | -$11.40M(+62.9%) | -$11.40M(+22.6%) |
| Sep 1991 | - | -$9.30M(+9.4%) |
| Jun 1991 | - | -$8.50M(+21.4%) |
| Dec 1990 | -$7.00M | -$7.00M |
FAQ
- What is Regeneron Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual retained earnings year-on-year change?
- What is Regeneron Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly retained earnings year-on-year change?
What is Regeneron Pharmaceuticals annual retained earnings?
The current annual retained earnings of REGN is $31.67B
What is the all time high annual retained earnings for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual retained earnings is $31.67B
What is Regeneron Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, REGN annual retained earnings has changed by +$4.41B (+16.19%)
What is Regeneron Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of REGN is $32.38B
What is the all time high quarterly retained earnings for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly retained earnings is $32.38B
What is Regeneron Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, REGN quarterly retained earnings has changed by +$4.40B (+15.73%)